What Changes for Supplement Brands in Late July 2026

1. The 10% import surcharge ends July 24

The temporary Section 122 surcharge, a 10% duty added to most non-exempt US imports since February 24, 2026, expires by operation of law at 12:01 a.m. EDT on July 24, 2026. Only Congress can extend it, and as of July 9 no extension bill was pending (Trade Act of 1974, Section 122; CBP CSMS #67844987; Nakachi Eckhardt & Jacobson trade-counsel analysis, July 4, 2026, accessed July 9, 2026).

What changes: a non-exempt Chinese botanical extract that faces roughly 17.5% to 35% in combined duties today drops back to the 7.5% to 25% Section 301 base after July 24. What does not change: Section 301 tariffs from the 2018-2019 trade actions, base MFN duties, and the exemptions for vitamins, amino acids, and CoQ10, which already face 0% from both programs.

Two cautions before you re-price. First, entry date controls: goods entered before July 24 still pay the surcharge. Second, a successor may be coming. USTR has proposed new Section 301 duties of 10% to 12.5% on imports from 60 economies in its forced-labor investigations. Public hearings ran July 7 to 9, and no final determination or effective date exists yet (USTR press releases, June 2 and July 2026, accessed July 9, 2026). Trade press positions these duties as the surcharge's replacement. Build your landed-cost models on the Section 301 base, and treat the July 24 savings as provisional until USTR acts. Our tariff estimator already reflects the expiration automatically.

2. GRAS reform is proposed, not law

FDA is moving to end the self-affirmed GRAS pathway, which lets companies conclude an ingredient is "generally recognized as safe" without notifying the agency. The draft rule sits at the White House regulatory-review office, with publication targeted for late 2026, and legal commentators still question FDA's authority to do this without new legislation (FDA Unified Agenda entry; Epstein Becker Green and Verdant Law analyses, accessed July 9, 2026).

Nothing changes today. But if your formulas rely on self-affirmed ingredients, now is the time to ask suppliers for their GRAS documentation and note which ingredients have an FDA "no questions" letter versus a self-affirmation file. Ingredients already covered by a GRAS regulation or a completed FDA notice would be exempt under the proposal as drafted.

3. Amazon's testing mandate is fully in effect

Since January 2026, Amazon requires every dietary supplement listing to be verified against FDA labeling and cGMP standards (21 CFR 101 and 21 CFR 111 or 117) through its approved Testing, Inspection, and Certification providers. The approved-provider list, which includes labs such as NSF, Eurofins, SGS, UL, and Intertek, is short and updates monthly inside Seller Central. Sellers contacted by Amazon typically get 90 days to submit verification (SupplySide Supplement Journal; Amazon Seller Central TIC program, accessed July 9, 2026).

If Amazon is in your channel plan, budget for TIC verification the way you budget for a certificate of analysis: per SKU, on a real calendar. Our Amazon supplement compliance guide covers the requirement in detail.

4. Ingredient markets are moving in opposite directions

Blanket "supply chain panic" is bad planning. Two current examples make the point.

Omega-3 supply is tightening. Peru's first anchovy season quota for 2026 came in at 1.91 million metric tons, a 36% cut from the roughly 3 million metric tons of early 2025, and analysts warn of fish-oil scarcity risk through the decade (NutraIngredients, April 15, 2026; Rabobank via SeafoodSource, accessed July 9, 2026). Suppliers are building inventory buffers. If fish oil is in your line, talk to your supplier about contract coverage and lead times now, before the next quota announcement.

Creatine is the opposite story. Chinese production capacity expanded sharply, and supplier market analyses report mid-2026 prices roughly half their early-2025 peak (Caloong Chemical price-trend analysis; Guidechem supply-chain report, accessed July 9, 2026). Buyers with creatine SKUs are negotiating from strength this year.

The lesson: price and availability are ingredient-specific. Check your actual bill of materials against current market data before accepting across-the-board increases.